Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh

PHASE3CompletedINTERVENTIONAL
Enrollment

204,438

Participants

Timeline

Start Date

December 9, 2012

Primary Completion Date

December 1, 2017

Study Completion Date

December 31, 2017

Conditions
Cholera
Interventions
BIOLOGICAL

Shanchol

"We will use the killed whole cell oral cholera vaccine, Shanchol that will be manufactured by Shantha Biotechnics, in Hyderabad, India for the study. The vaccine is registered in India and is prequalified by the WHO. Shanchol is available in a single dose vial. Vaccine will be maintained at 2-8oC. Each participant over the age of one year and non pregnant females living in communities will be individually randomized to receive vaccine.Pregnancy status will be enquired verbally for all married women of child bearing age during the census update as well as before vaccination to exclude them from the study.~Prior to vaccination, informed consent will be taken from the adults and guardians of minor participants .Each dose of vaccine will be 1.5 ml in volume."

BIOLOGICAL

Placebo

Placebo will be transported from the manufacturer and will be maintained at 2-8oC. Each participant over the age of one year and non pregnant females living in communities will be individually randomized to receive placebo.Each dose of placebo will be 1.5 ml in volume.Placebo will be dispensed in liquid form in identical vials.

Trial Locations (1)

1212

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka

All Listed Sponsors
collaborator

International Vaccine Institute

OTHER

collaborator

Government of Bangladesh

OTHER_GOV

lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

NCT02027207 - Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh | Biotech Hunter | Biotech Hunter